Faeth Therapeutics (FTH) Capital Leases (2020 - 2025)
Faeth Therapeutics' (FTH) quarterly Capital Leases came in at $4000.0 in Q2 2025, down 98.94% YoY from $377000.0 in Q2 2024, and down 88.57% on a QoQ basis from $35000.0 in Q1 2025.
Faeth Therapeutics (FTH) Capital Leases (2020 - 2025) Analysis & Trends
Faeth Therapeutics (FTH) has 6 years of Capital Leases data on file, last reported at $4000.0 in Q2 2025.
- Quarterly Capital Leases fell 98.94% year-over-year to $4000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $4000.0 (down 98.94% YoY) and the FY2024 annual result came in at $98000.0, down 87.24% from the prior year.
- Capital Leases fell to $4000.0 in Q2 2025, from $35000.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $1.8 million in Q1 2022 to a low of $4000.0 in Q2 2025.
- A 5-year average of $935066.7 and a median of $962000.0 in 2023 frame the typical range for Capital Leases.
- Annual changes were most pronounced in 2021 — Capital Leases soared 1846.51% — and 2025, when it sank 98.94%.
- Tracing FTH's Capital Leases over 5 years: stood at $1.7 million in 2021, then fell by 5.68% to $1.6 million in 2022, then plunged by 51.36% to $768000.0 in 2023, then slumped by 87.24% to $98000.0 in 2024, then tumbled by 95.92% to $4000.0 in 2025.
- The last three Capital Leases figures came in at $4000.0 (Q2 2025), $35000.0 (Q1 2025), and $98000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Faeth Therapeutics | 179.31 Mn | 179.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Dec 31, 2024 | 98,000.00 |
| Sep 30, 2024 | 206,000.00 |
| Jun 30, 2024 | 377,000.00 |
| Mar 31, 2024 | 571,000.00 |
| Dec 31, 2023 | 768,000.00 |
| Sep 30, 2023 | 962,000.00 |
| Jun 30, 2023 | 1.16 Mn |
| Mar 31, 2023 | 1.35 Mn |
| Dec 31, 2022 | 1.58 Mn |
| Sep 30, 2022 | 1.68 Mn |
| Jun 30, 2022 | 1.72 Mn |
| Mar 31, 2022 | 1.85 Mn |
| Dec 31, 2021 | 1.67 Mn |
| Dec 31, 2020 | 86,000.00 |